Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2021

Open Access 01-12-2021 | ST-Segment Elevation Myocardial Infarction | Research

ST-segment resolution as a marker for severe myocardial fibrosis in ST-segment elevation myocardial infarction

Authors: Qian Dong, Xuesong Wen, Guanglei Chang, Rui Xia, Sihang Wang, Yunjing Yang, Yi Tao, Dongying Zhang, Shu Qin

Published in: BMC Cardiovascular Disorders | Issue 1/2021

Login to get access

Abstract

Objective

To investigate the relationship between ST-segment resolution (STR) and myocardial scar thickness after percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI).

Methods

Forty-two STEMI patients with single-branch coronary artery stenosis or occlusion were enrolled. ST-segment elevations were measured at emergency admission and at 24 h after PCI. Late gadolinium-enhanced cardiac magnetic resonance imaging (CMR-LGE) was performed 7 days after PCI to evaluate myocardial scars. Statistical analyses were performed to assess the utility of STR to predict the development of transmural (> 75%) or non-transmural (< 75%) myocardial scars, according to previous study.

Results

The sensitivity and specificity of STR for predicting transmural scars were 96% and 88%, respectively, at an STR cut-off value of 40.15%. The area under the curve was 0.925. Multivariate logistic proportional hazards regression analysis disclosed that patients with STR < 40.15% had a 170.90-fold higher probability of developing transmural scars compared with patients with STR ≥ 40.15%. Pearson correlation and linear regression analyses showed STR percentage was significantly associated with myocardial scar thickness and size.

Conclusion

STR < 40.15% at 24 h after PCI may provide meaningful diagnostic information regarding the extent of myocardial scarification in STEMI patients.
Appendix
Available only for authorised users
Literature
1.
go back to reference Stone GW, Selker HP, Thiele H, Patel MR, Udelson JE, Ohman EM, et al. Relationship between infarct size and outcomes following primary PCI: patient-level analysis from 10 randomized trials. J Am Coll Cardiol. 2016;67(14):1674–83.CrossRef Stone GW, Selker HP, Thiele H, Patel MR, Udelson JE, Ohman EM, et al. Relationship between infarct size and outcomes following primary PCI: patient-level analysis from 10 randomized trials. J Am Coll Cardiol. 2016;67(14):1674–83.CrossRef
2.
go back to reference Schmidt A, Azevedo CF, Cheng A, Gupta SN, Bluemke DA, Foo TK, et al. Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation. 2007;115(15):2006–14.CrossRef Schmidt A, Azevedo CF, Cheng A, Gupta SN, Bluemke DA, Foo TK, et al. Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation. 2007;115(15):2006–14.CrossRef
3.
go back to reference Iles L, Pfluger H, Lefkovits L, Butler MJ, Kistler PM, Kaye DM, et al. Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. J Am Coll Cardiol. 2011;57(7):821–8.CrossRef Iles L, Pfluger H, Lefkovits L, Butler MJ, Kistler PM, Kaye DM, et al. Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. J Am Coll Cardiol. 2011;57(7):821–8.CrossRef
4.
go back to reference Klem I, Weinsaft JW, Bahnson TD, Hegland D, Kim HW, Hayes B, et al. Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation. J Am Coll Cardiol. 2012;60(5):408–20.CrossRef Klem I, Weinsaft JW, Bahnson TD, Hegland D, Kim HW, Hayes B, et al. Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation. J Am Coll Cardiol. 2012;60(5):408–20.CrossRef
5.
go back to reference Bello D, Fieno DS, Kim RJ, Pereles FS, Passman R, Song G, et al. Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. J Am Coll Cardiol. 2005;45(7):1104–8.CrossRef Bello D, Fieno DS, Kim RJ, Pereles FS, Passman R, Song G, et al. Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. J Am Coll Cardiol. 2005;45(7):1104–8.CrossRef
6.
go back to reference Izquierdo M, Ruiz-Granell R, Bonanad C, Chaustre F, Gomez C, Ferrero A, et al. Value of early cardiovascular magnetic resonance for the prediction of adverse arrhythmic cardiac events after a first noncomplicated ST-segment-elevation myocardial infarction. Circ Cardiovasc Imaging. 2013;6(5):755–61.CrossRef Izquierdo M, Ruiz-Granell R, Bonanad C, Chaustre F, Gomez C, Ferrero A, et al. Value of early cardiovascular magnetic resonance for the prediction of adverse arrhythmic cardiac events after a first noncomplicated ST-segment-elevation myocardial infarction. Circ Cardiovasc Imaging. 2013;6(5):755–61.CrossRef
7.
go back to reference Fernandez-Armenta J, Berruezo A, Mont L, Sitges M, Andreu D, Silva E, et al. Use of myocardial scar characterization to predict ventricular arrhythmia in cardiac resynchronization therapy. Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol. 2012;14(11):1578–86. Fernandez-Armenta J, Berruezo A, Mont L, Sitges M, Andreu D, Silva E, et al. Use of myocardial scar characterization to predict ventricular arrhythmia in cardiac resynchronization therapy. Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol. 2012;14(11):1578–86.
8.
go back to reference Wagner A, Mahrholdt H, Holly TA, Elliott MD, Regenfus M, Parker M, et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet. 2003;361(9355):374–9.CrossRef Wagner A, Mahrholdt H, Holly TA, Elliott MD, Regenfus M, Parker M, et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet. 2003;361(9355):374–9.CrossRef
9.
go back to reference Bulluck H, Dharmakumar R, Arai AE, Berry C, Hausenloy DJ. Cardiovascular magnetic resonance in acute ST-segment-elevation myocardial infarction: recent advances, controversies, and future directions. Circulation. 2018;137(18):1949–64.CrossRef Bulluck H, Dharmakumar R, Arai AE, Berry C, Hausenloy DJ. Cardiovascular magnetic resonance in acute ST-segment-elevation myocardial infarction: recent advances, controversies, and future directions. Circulation. 2018;137(18):1949–64.CrossRef
10.
go back to reference Schulz-Menger J, Bluemke DA, Bremerich J, Flamm SD, Fogel MA, Friedrich MG, et al. Standardized image interpretation and post-processing in cardiovascular magnetic resonance—2020 update: society for cardiovascular magnetic resonance (SCMR): board of trustees task force on standardized post-processing. J Cardiovasc Magn Reson. 2020;22(1):19.CrossRef Schulz-Menger J, Bluemke DA, Bremerich J, Flamm SD, Fogel MA, Friedrich MG, et al. Standardized image interpretation and post-processing in cardiovascular magnetic resonance—2020 update: society for cardiovascular magnetic resonance (SCMR): board of trustees task force on standardized post-processing. J Cardiovasc Magn Reson. 2020;22(1):19.CrossRef
11.
go back to reference Botker HE, Kaltoft AK, Pedersen SF, Kim WY. Measuring myocardial salvage. Cardiovasc Res. 2012;94(2):266–75.CrossRef Botker HE, Kaltoft AK, Pedersen SF, Kim WY. Measuring myocardial salvage. Cardiovasc Res. 2012;94(2):266–75.CrossRef
12.
go back to reference de Lemos JA, Antman EM, Giugliano RP, Morrow DA, McCabe CH, Cutler SS, et al. Comparison of a 60- versus 90-minute determination of ST-segment resolution after thrombolytic therapy for acute myocardial infarction. In TIME-II Investigators. Intravenous nPA for treatment of infarcting myocardium early-II. Am J Cardiol. 2000;86(11):1235–1127.CrossRef de Lemos JA, Antman EM, Giugliano RP, Morrow DA, McCabe CH, Cutler SS, et al. Comparison of a 60- versus 90-minute determination of ST-segment resolution after thrombolytic therapy for acute myocardial infarction. In TIME-II Investigators. Intravenous nPA for treatment of infarcting myocardium early-II. Am J Cardiol. 2000;86(11):1235–1127.CrossRef
13.
go back to reference Beek AM, Kuhl HP, Bondarenko O, Twisk JW, Hofman MB, van Dockum WG, et al. Delayed contrast-enhanced magnetic resonance imaging for the prediction of regional functional improvement after acute myocardial infarction. J Am Coll Cardiol. 2003;42(5):895–901.CrossRef Beek AM, Kuhl HP, Bondarenko O, Twisk JW, Hofman MB, van Dockum WG, et al. Delayed contrast-enhanced magnetic resonance imaging for the prediction of regional functional improvement after acute myocardial infarction. J Am Coll Cardiol. 2003;42(5):895–901.CrossRef
14.
go back to reference Schroder R, Wegscheider K, Schroder K, Dissmann R, Meyer-Sabellek W. Extent of early ST segment elevation resolution: a strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens. A substudy of the international joint efficacy comparison of thrombolytics (INJECT) trial. J Am Coll Cardiol. 1995;26(7):1657–64.CrossRef Schroder R, Wegscheider K, Schroder K, Dissmann R, Meyer-Sabellek W. Extent of early ST segment elevation resolution: a strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens. A substudy of the international joint efficacy comparison of thrombolytics (INJECT) trial. J Am Coll Cardiol. 1995;26(7):1657–64.CrossRef
15.
go back to reference Gragnano F, Spedicato V, Frigoli E, Gargiulo G, Di Maio D, Fimiani F, et al. ECG analysis in patients with acute coronary syndrome undergoing invasive management: rationale and design of the electrocardiography sub-study of the MATRIX trial. J Electrocardiol. 2019;57:44–54.CrossRef Gragnano F, Spedicato V, Frigoli E, Gargiulo G, Di Maio D, Fimiani F, et al. ECG analysis in patients with acute coronary syndrome undergoing invasive management: rationale and design of the electrocardiography sub-study of the MATRIX trial. J Electrocardiol. 2019;57:44–54.CrossRef
16.
go back to reference Calabrò P, Gragnano F, Di Maio M, Patti G, Antonucci E, Cirillo P, et al. Epidemiology and management of patients with acute coronary syndromes in contemporary real-world practice: evolving trends from the EYESHOT study to the START-ANTIPLATELET registry. Angiology. 2018;69(9):795–802.CrossRef Calabrò P, Gragnano F, Di Maio M, Patti G, Antonucci E, Cirillo P, et al. Epidemiology and management of patients with acute coronary syndromes in contemporary real-world practice: evolving trends from the EYESHOT study to the START-ANTIPLATELET registry. Angiology. 2018;69(9):795–802.CrossRef
17.
go back to reference de Lemos JA, Braunwald E. ST segment resolution as a tool for assessing the efficacy of reperfusion therapy. J Am Coll Cardiol. 2001;38(5):1283–94.CrossRef de Lemos JA, Braunwald E. ST segment resolution as a tool for assessing the efficacy of reperfusion therapy. J Am Coll Cardiol. 2001;38(5):1283–94.CrossRef
18.
go back to reference Angeja BG, Gunda M, Murphy SA, Sobel BE, Rundle AC, Syed M, et al. TIMI myocardial perfusion grade and ST segment resolution: association with infarct size as assessed by single photon emission computed tomography imaging. Circulation. 2002;105(3):282–5.CrossRef Angeja BG, Gunda M, Murphy SA, Sobel BE, Rundle AC, Syed M, et al. TIMI myocardial perfusion grade and ST segment resolution: association with infarct size as assessed by single photon emission computed tomography imaging. Circulation. 2002;105(3):282–5.CrossRef
19.
go back to reference Bendary A, Tawfeek W, Mahros M, Salem M. Impact of ST-segment resolution on clinical outcome in patients with ST-segment elevation myocardial infarction and preserved left ventricular function. Ann Noninvasive Electrocardiol. 2018;23(5):e12562.CrossRef Bendary A, Tawfeek W, Mahros M, Salem M. Impact of ST-segment resolution on clinical outcome in patients with ST-segment elevation myocardial infarction and preserved left ventricular function. Ann Noninvasive Electrocardiol. 2018;23(5):e12562.CrossRef
20.
go back to reference Carrick D, Haig C, Carberry J, May VTY, McCartney P, Welsh P, et al. Microvascular resistance of the culprit coronary artery in acute ST-elevation myocardial infarction. JCI Insight. 2016;1(6):e85768.CrossRef Carrick D, Haig C, Carberry J, May VTY, McCartney P, Welsh P, et al. Microvascular resistance of the culprit coronary artery in acute ST-elevation myocardial infarction. JCI Insight. 2016;1(6):e85768.CrossRef
21.
go back to reference Rakowski T, Dziewierz A, Siudak Z, Mielecki W, Brzozowska-Czarnek A, Legutko J, et al. ST-segment resolution assessed immediately after primary percutaneous coronary intervention correlates with infarct size and left ventricular function in cardiac magnetic resonance at 1-year follow-up. J Electrocardiol. 2009;42(2):152–6.CrossRef Rakowski T, Dziewierz A, Siudak Z, Mielecki W, Brzozowska-Czarnek A, Legutko J, et al. ST-segment resolution assessed immediately after primary percutaneous coronary intervention correlates with infarct size and left ventricular function in cardiac magnetic resonance at 1-year follow-up. J Electrocardiol. 2009;42(2):152–6.CrossRef
22.
go back to reference Dong J, Ndrepepa G, Schmitt C, Mehilli J, Schmieder S, Schwaiger M, et al. Early resolution of ST-segment elevation correlates with myocardial salvage assessed by Tc-99m sestamibi scintigraphy in patients with acute myocardial infarction after mechanical or thrombolytic reperfusion therapy. Circulation. 2002;105(25):2946–9.CrossRef Dong J, Ndrepepa G, Schmitt C, Mehilli J, Schmieder S, Schwaiger M, et al. Early resolution of ST-segment elevation correlates with myocardial salvage assessed by Tc-99m sestamibi scintigraphy in patients with acute myocardial infarction after mechanical or thrombolytic reperfusion therapy. Circulation. 2002;105(25):2946–9.CrossRef
23.
go back to reference Sezer M, Nisanci Y, Umman B, Yilmaz E, Olcay A, Erzengin F, et al. New support for clarifying the relation between ST segment resolution and microvascular function: degree of ST segment resolution correlates with the pressure derived collateral flow index. Heart. 2004;90(2):146–50.CrossRef Sezer M, Nisanci Y, Umman B, Yilmaz E, Olcay A, Erzengin F, et al. New support for clarifying the relation between ST segment resolution and microvascular function: degree of ST segment resolution correlates with the pressure derived collateral flow index. Heart. 2004;90(2):146–50.CrossRef
24.
go back to reference Purcell IF, Newall N, Farrer M. Change in ST segment elevation 60 minutes after thrombolytic initiation predicts clinical outcome as accurately as later electrocardiographic changes. Heart. 1997;78(5):465–71.CrossRef Purcell IF, Newall N, Farrer M. Change in ST segment elevation 60 minutes after thrombolytic initiation predicts clinical outcome as accurately as later electrocardiographic changes. Heart. 1997;78(5):465–71.CrossRef
25.
go back to reference Roes SD, Kelle S, Kaandorp TA, Kokocinski T, Poldermans D, Lamb HJ, et al. Comparison of myocardial infarct size assessed with contrast-enhanced magnetic resonance imaging and left ventricular function and volumes to predict mortality in patients with healed myocardial infarction. Am J Cardiol. 2007;100(6):930–6.CrossRef Roes SD, Kelle S, Kaandorp TA, Kokocinski T, Poldermans D, Lamb HJ, et al. Comparison of myocardial infarct size assessed with contrast-enhanced magnetic resonance imaging and left ventricular function and volumes to predict mortality in patients with healed myocardial infarction. Am J Cardiol. 2007;100(6):930–6.CrossRef
26.
go back to reference Cheong BY, Muthupillai R, Wilson JM, Sung A, Huber S, Amin S, et al. Prognostic significance of delayed-enhancement magnetic resonance imaging: survival of 857 patients with and without left ventricular dysfunction. Circulation. 2009;120(21):2069–76.CrossRef Cheong BY, Muthupillai R, Wilson JM, Sung A, Huber S, Amin S, et al. Prognostic significance of delayed-enhancement magnetic resonance imaging: survival of 857 patients with and without left ventricular dysfunction. Circulation. 2009;120(21):2069–76.CrossRef
27.
go back to reference Daniels A, van Bilsen M, Goldschmeding R, van der Vusse GJ, van Nieuwenhoven FA. Connective tissue growth factor and cardiac fibrosis. Acta Physiol (Oxf). 2009;195(3):321–38.CrossRef Daniels A, van Bilsen M, Goldschmeding R, van der Vusse GJ, van Nieuwenhoven FA. Connective tissue growth factor and cardiac fibrosis. Acta Physiol (Oxf). 2009;195(3):321–38.CrossRef
28.
go back to reference Choi JH, Chang SA, Choi JO, Song YB, Hahn JY, Choi SH, et al. Frequency of myocardial infarction and its relationship to angiographic collateral flow in territories supplied by chronically occluded coronary arteries. Circulation. 2013;127(6):703–9.CrossRef Choi JH, Chang SA, Choi JO, Song YB, Hahn JY, Choi SH, et al. Frequency of myocardial infarction and its relationship to angiographic collateral flow in territories supplied by chronically occluded coronary arteries. Circulation. 2013;127(6):703–9.CrossRef
29.
go back to reference Greulich S, Mayr A, Gloekler S, Seitz A, Birkmeier S, Schaufele T, et al. Time-dependent myocardial necrosis in patients with ST-segment-elevation myocardial infarction without angiographic collateral flow visualized by cardiac magnetic resonance imaging: results from the multicenter STEMI-SCAR project. J Am Heart Assoc. 2019;8(12):e012429.CrossRef Greulich S, Mayr A, Gloekler S, Seitz A, Birkmeier S, Schaufele T, et al. Time-dependent myocardial necrosis in patients with ST-segment-elevation myocardial infarction without angiographic collateral flow visualized by cardiac magnetic resonance imaging: results from the multicenter STEMI-SCAR project. J Am Heart Assoc. 2019;8(12):e012429.CrossRef
30.
go back to reference Hoole SP, White PA, Read PA, Heck PM, West NE, O’Sullivan M, et al. Coronary collaterals provide a constant scaffold effect on the left ventricle and limit ischemic left ventricular dysfunction in humans. J Appl Physiol. 2012;112(8):1403–9.CrossRef Hoole SP, White PA, Read PA, Heck PM, West NE, O’Sullivan M, et al. Coronary collaterals provide a constant scaffold effect on the left ventricle and limit ischemic left ventricular dysfunction in humans. J Appl Physiol. 2012;112(8):1403–9.CrossRef
31.
go back to reference Chery G, Kamp N, Kosinski AS, Schmidler GS, Lopes RD, Patel M, et al. Prognostic value of myocardial fibrosis on cardiac magnetic resonance imaging in patients with ischemic cardiomyopathy: a systematic review. Am Heart J. 2020;229:52–60.CrossRef Chery G, Kamp N, Kosinski AS, Schmidler GS, Lopes RD, Patel M, et al. Prognostic value of myocardial fibrosis on cardiac magnetic resonance imaging in patients with ischemic cardiomyopathy: a systematic review. Am Heart J. 2020;229:52–60.CrossRef
32.
go back to reference Cojan-Minzat BO, Zlibut A, Muresan ID, Cionca C, Horvat D, Kiss E, et al. Left ventricular geometry and replacement fibrosis detected by cMRI are associated with major adverse cardiovascular events in nonischemic dilated cardiomyopathy. J Clin Med. 2020;9(6):1997.CrossRef Cojan-Minzat BO, Zlibut A, Muresan ID, Cionca C, Horvat D, Kiss E, et al. Left ventricular geometry and replacement fibrosis detected by cMRI are associated with major adverse cardiovascular events in nonischemic dilated cardiomyopathy. J Clin Med. 2020;9(6):1997.CrossRef
33.
go back to reference von Lueder TG, Wang BH, Kompa AR, Huang L, Webb R, Jordaan P, et al. Angiotensin receptor neprilysin inhibitor LCZ696 attenuates cardiac remodeling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophy. Circ Heart Fail. 2015;8(1):71–8.CrossRef von Lueder TG, Wang BH, Kompa AR, Huang L, Webb R, Jordaan P, et al. Angiotensin receptor neprilysin inhibitor LCZ696 attenuates cardiac remodeling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophy. Circ Heart Fail. 2015;8(1):71–8.CrossRef
34.
go back to reference Chen Y, Yang S, Yao W, Zhu H, Xu X, Meng G, et al. Prostacyclin analogue beraprost inhibits cardiac fibroblast proliferation depending on prostacyclin receptor activation through a TGF beta-Smad signal pathway. PLoS ONE. 2014;9(5):e98483.CrossRef Chen Y, Yang S, Yao W, Zhu H, Xu X, Meng G, et al. Prostacyclin analogue beraprost inhibits cardiac fibroblast proliferation depending on prostacyclin receptor activation through a TGF beta-Smad signal pathway. PLoS ONE. 2014;9(5):e98483.CrossRef
35.
go back to reference Nguyen MN, Kiriazis H, Ruggiero D, Gao XM, Su Y, Jian A, et al. Spontaneous ventricular tachyarrhythmias in beta2-adrenoceptor transgenic mice in relation to cardiac interstitial fibrosis. Am J Physiol Heart Circ Physiol. 2015;309(5):H946–57.CrossRef Nguyen MN, Kiriazis H, Ruggiero D, Gao XM, Su Y, Jian A, et al. Spontaneous ventricular tachyarrhythmias in beta2-adrenoceptor transgenic mice in relation to cardiac interstitial fibrosis. Am J Physiol Heart Circ Physiol. 2015;309(5):H946–57.CrossRef
36.
go back to reference Webber M, Jackson SP, Moon JC, Captur G. Myocardial fibrosis in heart failure: anti-fibrotic therapies and the role of cardiovascular magnetic resonance in drug trials. Cardiol Ther. 2020;9(2):363–76.CrossRef Webber M, Jackson SP, Moon JC, Captur G. Myocardial fibrosis in heart failure: anti-fibrotic therapies and the role of cardiovascular magnetic resonance in drug trials. Cardiol Ther. 2020;9(2):363–76.CrossRef
37.
go back to reference Kim BG, Cho SW, Ha JH, Ahn HS, Lee HY, Kim GS, et al. Relationship between the ST-segment resolution and microvascular dysfunction in patients who underwent primary percutaneous coronary intervention. Cardiol Res Pract. 2019;2019:8695065.CrossRef Kim BG, Cho SW, Ha JH, Ahn HS, Lee HY, Kim GS, et al. Relationship between the ST-segment resolution and microvascular dysfunction in patients who underwent primary percutaneous coronary intervention. Cardiol Res Pract. 2019;2019:8695065.CrossRef
38.
go back to reference Ndrepepa G, Alger P, Kufner S, Mehilli J, Schomig A, Kastrati A. ST-segment resolution after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction. Cardiol J. 2012;19(1):61–9.CrossRef Ndrepepa G, Alger P, Kufner S, Mehilli J, Schomig A, Kastrati A. ST-segment resolution after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction. Cardiol J. 2012;19(1):61–9.CrossRef
Metadata
Title
ST-segment resolution as a marker for severe myocardial fibrosis in ST-segment elevation myocardial infarction
Authors
Qian Dong
Xuesong Wen
Guanglei Chang
Rui Xia
Sihang Wang
Yunjing Yang
Yi Tao
Dongying Zhang
Shu Qin
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2021
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-021-02269-y

Other articles of this Issue 1/2021

BMC Cardiovascular Disorders 1/2021 Go to the issue